Paul R. Edick, See Remarks at Xeris Biopharma Holdings, Inc. (XERS), bought 200,000 shares at $2.08 ($416K) on 2021-11-11, disclosed to the SEC on 2021-11-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| XERS | BUY | 2022-05-13 | $140K | — | Filing → |
| XERS | BUY | 2021-11-16 | $46K | — | Filing → |
| XERS | BUY | 2020-12-10 | $41K | — | Filing → |